Matches in Nanopublications for { ?s ?p "[B72.3, Ber-EP4, carcinoembryonic antigen, and vimentin are useful immunohistochemical markers in differentiating malignant mesotheliomas from adenocarcinomas, whereas immunohistochemistry does not reliably distinguish malignant from benign hyperplastic mesothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP697046.RAA_cmZBlMGrdbKOTdvqGFOiBwaJgErSuOuzgQ-xbxBaQ130_assertion description "[B72.3, Ber-EP4, carcinoembryonic antigen, and vimentin are useful immunohistochemical markers in differentiating malignant mesotheliomas from adenocarcinomas, whereas immunohistochemistry does not reliably distinguish malignant from benign hyperplastic mesothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697046.RAA_cmZBlMGrdbKOTdvqGFOiBwaJgErSuOuzgQ-xbxBaQ130_provenance.
- assertion description "[B72.3, Ber-EP4, carcinoembryonic antigen, and vimentin are useful immunohistochemical markers in differentiating malignant mesotheliomas from adenocarcinomas, whereas immunohistochemistry does not reliably distinguish malignant from benign hyperplastic mesothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP785210.RAaQXwSjC8lMlMTN6Pzoys35SCv1jzrpQHwfd1zUHRzCk130_assertion description "[B72.3, Ber-EP4, carcinoembryonic antigen, and vimentin are useful immunohistochemical markers in differentiating malignant mesotheliomas from adenocarcinomas, whereas immunohistochemistry does not reliably distinguish malignant from benign hyperplastic mesothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785210.RAaQXwSjC8lMlMTN6Pzoys35SCv1jzrpQHwfd1zUHRzCk130_provenance.
- NP718054.RA9beagpMO88vm3nwFeCwlPYet3pzkTAx1kss6EoN7WVg130_assertion description "[B72.3, Ber-EP4, carcinoembryonic antigen, and vimentin are useful immunohistochemical markers in differentiating malignant mesotheliomas from adenocarcinomas, whereas immunohistochemistry does not reliably distinguish malignant from benign hyperplastic mesothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718054.RA9beagpMO88vm3nwFeCwlPYet3pzkTAx1kss6EoN7WVg130_provenance.
- assertion description "[B72.3, Ber-EP4, carcinoembryonic antigen, and vimentin are useful immunohistochemical markers in differentiating malignant mesotheliomas from adenocarcinomas, whereas immunohistochemistry does not reliably distinguish malignant from benign hyperplastic mesothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[B72.3, Ber-EP4, carcinoembryonic antigen, and vimentin are useful immunohistochemical markers in differentiating malignant mesotheliomas from adenocarcinomas, whereas immunohistochemistry does not reliably distinguish malignant from benign hyperplastic mesothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP774403.RA-ph4IYJkBO0BdTMSS8soQlF2drRXFvMV-aebMhR6dqI130_assertion description "[B72.3, Ber-EP4, carcinoembryonic antigen, and vimentin are useful immunohistochemical markers in differentiating malignant mesotheliomas from adenocarcinomas, whereas immunohistochemistry does not reliably distinguish malignant from benign hyperplastic mesothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP774403.RA-ph4IYJkBO0BdTMSS8soQlF2drRXFvMV-aebMhR6dqI130_provenance.
- NP356803.RA-B2sVZnq2jltZL7eo2T7leZo2VzuP6Pk-9Gp9G4FLtY130_assertion description "[B72.3, Ber-EP4, carcinoembryonic antigen, and vimentin are useful immunohistochemical markers in differentiating malignant mesotheliomas from adenocarcinomas, whereas immunohistochemistry does not reliably distinguish malignant from benign hyperplastic mesothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356803.RA-B2sVZnq2jltZL7eo2T7leZo2VzuP6Pk-9Gp9G4FLtY130_provenance.
- NP356804.RA2mQF1xVYn2wTmnktEo1FS9a4dFTpIU8Vetc9Apl6i90130_assertion description "[B72.3, Ber-EP4, carcinoembryonic antigen, and vimentin are useful immunohistochemical markers in differentiating malignant mesotheliomas from adenocarcinomas, whereas immunohistochemistry does not reliably distinguish malignant from benign hyperplastic mesothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356804.RA2mQF1xVYn2wTmnktEo1FS9a4dFTpIU8Vetc9Apl6i90130_provenance.